Ligand validation:3SH1

NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose

NAG is a Ligand Of Interest in 3SH1 designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
3SH1_NAG_F_250	49%	61%	0.144	0.889	0.52	0.96	-	1	0	0	100%	0.9333
3SH1_NAG_B_250	41%	54%	0.188	0.905	0.67	1.11	-	-	1	0	100%	0.9333
3SH1_NAG_I_250	36%	53%	0.143	0.833	0.62	1.18	-	3	3	0	100%	0.9333
3SH1_NAG_C_250	33%	27%	0.193	0.87	1.11	1.98	1	4	2	0	100%	0.9333
3SH1_NAG_I_275	5%	41%	0.259	0.664	1.32	1.02	1	1	0	0	100%	0.4667
3SH1_NAG_B_275	3%	57%	0.349	0.669	0.61	1	-	-	0	0	100%	0.56
3SH1_NAG_E_275	1%	41%	0.391	0.589	1.32	1.05	1	1	0	0	100%	0.4667
3SIO_NAG_C_225	57%	59%	0.136	0.912	0.47	1.08	-	1	0	0	100%	0.9333
1OC7_NAG_A_500	100%	60%	0.04	0.991	0.61	0.9	-	1	0	0	100%	0.9333
1OC6_NAG_A_500	100%	67%	0.041	0.988	0.46	0.8	-	1	0	0	100%	0.9333
1UWC_NAG_A_262	100%	54%	0.046	0.99	0.81	0.95	-	-	0	0	100%	0.9333
6ZE6_NAG_B_703	99%	52%	0.044	0.984	0.78	1.07	-	2	0	0	100%	0.8667
6ZE2_NAG_B_704	99%	56%	0.042	0.979	0.73	0.95	-	1	0	0	100%	0.9333

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.